Compare SANA & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SANA | PWP |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2020 |
| Metric | SANA | PWP |
|---|---|---|
| Price | $3.15 | $16.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $7.50 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 1.8M | 806.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | 17.24 | ★ 138.52 |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.87 |
| Revenue Next Year | N/A | $17.25 |
| P/E Ratio | ★ N/A | $35.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $14.44 |
| 52 Week High | $6.55 | $25.93 |
| Indicator | SANA | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 29.26 |
| Support Level | $2.85 | N/A |
| Resistance Level | $3.24 | $19.49 |
| Average True Range (ATR) | 0.26 | 0.82 |
| MACD | -0.08 | -0.34 |
| Stochastic Oscillator | 6.42 | 21.35 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.